Nihon Kohden Corporation (OTCMKTS:NHNKY) Short Interest Up 104.6% in June

Nihon Kohden Corporation (OTCMKTS:NHNKY) was the recipient of a significant growth in short interest during the month of June. As of June 15th, there was short interest totaling 8,583 shares, a growth of 104.6% from the May 31st total of 4,196 shares. Based on an average trading volume of 28,647 shares, the short-interest ratio is currently 0.3 days. Approximately 0.0% of the company’s shares are short sold.

Nihon Kohden Price Performance

Shares of OTCMKTS NHNKY opened at $8.70 on Thursday. The firm has a market cap of $1.46 billion, a price-to-earnings ratio of 14.75 and a beta of 0.39. Nihon Kohden has a 52-week low of $8.12 and a 52-week high of $14.21. The business’s 50 day moving average is $8.96 and its two-hundred day moving average is $10.03.

Nihon Kohden (OTCMKTS:NHNKY) last released its quarterly earnings results on Thursday, May 14th. The company reported $0.34 EPS for the quarter, topping analysts’ consensus estimates of $0.24 by $0.10. Nihon Kohden had a return on equity of 9.46% and a net margin of 6.08%.The company had revenue of $453.10 million for the quarter, compared to analysts’ expectations of $414.40 million. Analysts anticipate that Nihon Kohden will post 0.6 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded Nihon Kohden to a “hold” rating in a report on Monday, April 27th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Buy”.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.